These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32821044)

  • 1. [Organic cation transporters as novel therapeutic targets for depression].
    Gautron S; Pietranscosta N
    Med Sci (Paris); 2020; 36(8-9):703-705. PubMed ID: 32821044
    [No Abstract]   [Full Text] [Related]  

  • 2. [New hopes for the treatment of persistent Mycobacterium abscessus infections?].
    Raynaud C; Kremer L
    Med Sci (Paris); 2020; 36(8-9):691-694. PubMed ID: 32821041
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA repair: a reinvigorated therapeutic target.
    Bates SE
    Clin Cancer Res; 2010 Sep; 16(18):4510. PubMed ID: 20823139
    [No Abstract]   [Full Text] [Related]  

  • 4. [Meningeal lymphatics, a potential target for the treatment of brain tumors].
    Thomas JL; Song E; Boisserand L; Iwasaki A
    Med Sci (Paris); 2020; 36(8-9):709-713. PubMed ID: 32821046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [G-protein-coupled receptors, the beginning of a new era for therapeutic innovation].
    Bril A; Combettes M; Audinot V
    Med Sci (Paris); 2012 Oct; 28(10):799-800. PubMed ID: 23067404
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
    Moreno L; Barone G; DuBois SG; Molenaar J; Fischer M; Schulte J; Eggert A; Schleiermacher G; Speleman F; Chesler L; Geoerger B; Hogarty MD; Irwin MS; Bird N; Blanchard GB; Buckland S; Caron H; Davis S; De Wilde B; Deubzer HE; Dolman E; Eilers M; George RE; George S; Jaroslav Š; Maris JM; Marshall L; Merchant M; Mortimer P; Owens C; Philpott A; Poon E; Shay JW; Tonelli R; Valteau-Couanet D; Vassal G; Park JR; Pearson ADJ
    Eur J Cancer; 2020 Sep; 136():52-68. PubMed ID: 32653773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TGF-β-targeted immunotherapy aiming for new and efficient treatments of cancer].
    Foughali R; Marie JC
    Med Sci (Paris); 2020 Jan; 36(1):77-79. PubMed ID: 32014103
    [No Abstract]   [Full Text] [Related]  

  • 8. [Opening the brain to new therapies].
    Collin L
    Med Sci (Paris); 2014 May; 30(5):486-8. PubMed ID: 24939528
    [No Abstract]   [Full Text] [Related]  

  • 9. The Inflammasome in Reproductive Biology: A Promising Target for Novel Therapies.
    de Rivero Vaccari JP
    Front Endocrinol (Lausanne); 2020; 11():8. PubMed ID: 32047476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma: Novel precision therapies.
    Mondello P; Mian M; Bertoni F
    Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.
    Cole PE; Schwarz AJ; Schmidt ME
    Clin Pharmacol Ther; 2012 Feb; 91(2):315-20. PubMed ID: 22218072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital phenotyping approaches and mobile devices enhance CNS biopharmaceutical research and development.
    Smith DG
    Neuropsychopharmacology; 2018 Dec; 43(13):2504-2505. PubMed ID: 30267015
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bronchial smooth muscle mitochondria: A new target for asthma therapy?].
    Esteves P; Celle A; Berger P; Trian T
    Rev Mal Respir; 2020 Mar; 37(3):201-204. PubMed ID: 32139106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic potential of ambroxol for motor neuron diseases].
    Bouscary A; Quessada C
    Med Sci (Paris); 2020 May; 36(5):447-448. PubMed ID: 32452362
    [No Abstract]   [Full Text] [Related]  

  • 15. [New treatments for metastatic melanoma: a first hope].
    Robert C; Mateus C
    Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
    [No Abstract]   [Full Text] [Related]  

  • 16. [The RARE 2017 meeting for companies developing products for rare patients].
    Ferry A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():7. PubMed ID: 29911542
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development.
    Kaffman A; White JD; Wei L; Johnson FK; Krystal JH
    Methods Mol Biol; 2019; 2011():3-22. PubMed ID: 31273690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible Treatment of Neuropsychiatric Disorders by Promotion of Neuronal Differentiation through Organic Cation Transporters].
    Nakamichi N; Masuo Y; Kato Y
    Yakugaku Zasshi; 2019; 139(6):847-852. PubMed ID: 31155524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HSP27: A new target for treating idiopathic pulmonary fibrosis?].
    Pommerolle L; Burgy O; Bonniaud P; Goirand F
    Rev Mal Respir; 2020 Mar; 37(3):210-213. PubMed ID: 32146056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trials as valid therapeutic options for patients with cancer.
    Adashek JJ; LoRusso PM; Hong DS; Kurzrock R
    Nat Rev Clin Oncol; 2019 Dec; 16(12):773-778. PubMed ID: 31477881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.